The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Genetics of drug‐induced liver injury: Current knowledge and future prospects
Abstract
Idiosyncratic drug‐induced liver injury (DILI) remains an important clinical problem, both during drug development and the prescription of a range of licensed drugs. Although rare, the consequences are serious. Ongoing studies on genetic risk factors for DILI, especially genomewide association studies, have resulted in the identification of a number of genetic risk factors, including particular HLA alleles and a few non‐HLA genes, both immune‐related and metabolic. Some non‐HLA associations, such as N‐acetyltransferase 2 in isoniazid DILI and interferon regulatory factor 6 in interferon‐beta DILI are likely to be drug‐specific due to the role of the associated gene, but there is also evidence for polygenic susceptibility involving pathways such as oxidative and endoplasmic reticulum stress and mitochondrial function for DILI induced by multiple drugs. Increased knowledge of genetic risk factors should assist in better understanding underlying DILI mechanisms and help improve methods for identifying hepatotoxic drugs early in development. HLA allele‐specific T cell proliferation together with in silico prediction of drug binding to specific HLA proteins have confirmed genetic findings for certain common causes of DILI. However, studies in hepatocytes exposed to high drug concentrations suggest toxicity that is not dependent on genotype also occurs. It seems likely that susceptibility to DILI involves several genetic risk factors combining with other factors that affect drug levels. Despite recent progress in detecting genetic risk factors for DILI, low positive predictive values mean that general implementation of genotyping prior to prescription of potentially hepatotoxic drugs is not useful currently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All available genome‐wide association studies have identified distinct HLA alleles that modulate the predisposition to DILI in association with specific drugs.”
From Methods for causality assessment of idiosyncratic drug‐induced liver injury (2025) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2
McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000062 · Cited by 146
Germline Mutations in CIDEB and Protection against Liver Disease
Verweij, N., Haas, M. E., Nielsen, J. B., Sosina, O. A., Kim, M., Akbari, P., De, T., Hindy, G., Bovijn, J., Persaud, T., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2117872 · Cited by 127
Li, Y., Phillips, E. J., Dellinger, A., Nicoletti, P., Schutte, R., Li, D., Ostrov, D. A., Fontana, R. J., Watkins, P. B., Stolz, A., et al. (2021) · Hepatology · doi:10.1002/hep.31258 · Cited by 76
Self-citation
Research works printed but not linked: 26
- 10.1007/s40264-021-01109-4 · DOI
- 10.1111/liv.15378 · DOI · Paper page
- 10.1016/S0016-5085(99)70404-X · DOI · Paper page
- 10.1038/ng.379 · DOI · Paper page
- 10.1038/tpj.2008.4 · DOI
- 10.1053/j.gastro.2016.12.016 · DOI · Paper page
- 10.1053/j.gastro.2019.01.034 · DOI · Paper page
- Nicoletti P, 2019, Discovery of ERAP2 gene expression as a risk factor for drug‐induced liver injury due to amoxicillin‐clavulanic acid, Hepatology, 70, 137A
- 10.1097/MOG.0000000000000822 · DOI
- 10.1038/s41588-018-0168-y · DOI
- 10.1038/s41591-020-1023-0 · DOI · Paper page
- 10.1128/AAC.02692-18 · DOI
- 10.1053/jhep.2002.32102 · DOI · Paper page
- 10.1002/cpt.2100 · DOI · Paper page
- 10.3389/fgene.2021.652704 · DOI
- 10.1007/s00228-012-1429-9 · DOI · Paper page
- 10.1124/dmd.118.082719 · DOI
- 10.1002/cpt.2343 · doi:10.1002/cpt.2343
- 10.1002/hep.26077 · DOI · Paper page
- 10.1002/hep.27912 · DOI
- 10.1021/acs.chemrestox.8b00163 · DOI
- 10.1021/acs.chemrestox.6b00400 · doi:10.1021/acs.chemrestox.6b00400
- 10.1016/j.jhep.2017.03.010 · DOI · Paper page
- 10.1016/j.freeradbiomed.2017.11.017 · DOI
- 10.1016/j.fct.2021.112664 · DOI
- 10.1016/j.yamp.2020.07.010 · DOI
Cited by
Methods for causality assessment of idiosyncratic drug‐induced liver injury
García‐Cortés, M., Matilla‐Cabello, G., & Lucena, M. I. (2025) · Liver International · doi:10.1111/liv.16083 · Cited by 15
“10,63 However, the rare occurrence of DILI in relation to a specific drug suggests that the positive predictive value of such associations is quite low.”
Metadata
- Authors
- Daly, A. K.
- Affiliations
- Translational & Clinical Research Institute Newcastle University Newcastle upon Tyne UK
- Venue
- Clinical and Translational Science
- Publisher
- Wiley
- Published
- 2022-10-04
- Volume
- 16
- Issue
- 1
- Pages
- 37-42
- ISSN
- 1752-8054
- 1752-8062
- Cited by
- 41
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.